Womens Gentle Laxative Tablet
NDC Package 11673-151-52

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Womens Gentle Laxative (bisacodyl) tablets is bisacodyl is used to treat constipation. This formulation utilizes a tablet delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-151 and is authorized under FDA application part334.

Identification & Billing

NDC Package Code
11673-151-52
Package Description
25 TABLET in 1 CARTON
Product Code
11673-151
11-Digit Billing Format
11673015152
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Womens Gentle Laxative
Non-Proprietary Name
Bisacodyl
Substance Name
Bisacodyl
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BISACODYL 5 mg/1
Pharmacologic Class
Usage Information
Bisacodyl is used to treat constipation. It may also be used to clean out the intestines before a bowel examination/surgery. Bisacodyl is known as a stimulant laxative. It works by increasing the movement of the intestines, helping the stool to come out.

Regulatory & Marketing

Labeler Name
Target Corporation
Product Type
Human Otc Drug
FDA Application #
part334
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
04-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 11673-151-52 identifies a specific commercial package of 25 tablet in 1 carton of Womens Gentle Laxative, a human over the counter drug labeled by Target Corporation. This tablet is formulated for oral use and contains bisacodyl as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on April 01, 2019. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Bisacodyl is used to treat constipation. It may also be used to clean out the intestines before a bowel examination/surgery. Bisacodyl is known as a stimulant laxative. It works by increasing the movement of the intestines, helping the stool to come out.

How is this Target Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673015152. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
11673-151-52
11-Digit CMS (5-4-2)
11673-0151-52

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.